The Pennant Group, Inc. (PNTG)
NASDAQ: PNTG · Real-Time Price · USD
24.27
+0.19 (0.79%)
At close: Sep 5, 2025, 4:00 PM
23.81
-0.46 (-1.90%)
After-hours: Sep 5, 2025, 5:51 PM EDT
The Pennant Group Market Cap
The Pennant Group has a market cap or net worth of $839.51 million as of September 5, 2025. Its market cap has decreased by -13.34% in one year.
Market Cap
839.51M
Enterprise Value
1.14B
1-Year Change
-13.34%
Ranking
Category
Stock Price
$24.27
Market Cap Chart
Since October 1, 2019, The Pennant Group's market cap has increased from $422.52M to $839.51M, an increase of 98.69%. That is a compound annual growth rate of 12.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 839.51M | -7.84% |
| Dec 31, 2024 | 910.92M | 118.67% |
| Dec 29, 2023 | 416.58M | 27.84% |
| Dec 30, 2022 | 325.85M | -50.42% |
| Dec 31, 2021 | 657.25M | -59.84% |
| Dec 31, 2020 | 1.64B | 77.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.38B |
| Johnson & Johnson | 428.68B |
| AbbVie | 374.26B |
| UnitedHealth Group | 278.84B |
| AstraZeneca | 254.65B |
| Novo Nordisk | 253.55B |
| Novartis AG | 248.54B |
| Abbott Laboratories | 230.05B |